In the current study, we investigated the performance of Gas6 and Gas6/alb for the detection and prediction of significant to advanced liver fibrosis, compensated and decompensated liver cirrhosis, CSPH, transplant-free survival, and HCC in a large Central European multicentric cohort. Here, GAS6 is linked to hepatocellular carcinoma.